Medicare Enrolled
Dr. Moustafa Ahmed, MD
Anesthesiology · Webster, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ahmed from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ahmed?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ahmed
Dr. Moustafa Ahmed is an anesthesiology specialist in Webster, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ahmed performed 3,417 Medicare services across 1,431 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ahmed received a total of $7,918 from 41 pharmaceutical and/or device companies across 172 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in anesthesiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ahmed is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 3% volume in TX
$7,918 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,417
Medicare services
Top 3% in TX for anesthesiology
1,431
Unique beneficiaries
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~180 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
982 | $94 | $317 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
344 | $60 | $186 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
270 | $239 | $741 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
251 | $95 | $389 |
| Lidocaine HCl injection for IV infusion, 10 mg Administration of a 10 mg dose of lidocaine hydrochloride via intravenous infusion. |
222 | $0 | $1 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
198 | $0 | $1 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
192 | $138 | $609 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
186 | $1 | $2 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
153 | $63 | $220 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
109 | $0 | $1 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
106 | $131 | $506 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
55 | $73 | $305 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
30 | $70 | $273 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
27 | $45 | $177 |
| Injection, methylprednisolone acetate, 40 mg | 27 | $0 | $1 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
26 | $155 | $517 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
26 | $200 | $752 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
26 | $91 | $342 |
| Bupivacaine injection, 0.5 mg An injection of bupivacaine, a local anesthetic, administered in a dose of 0.5 mg. |
26 | $0 | $15 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
21 | $234 | $733 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
19 | $202 | $794 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
19 | $154 | $539 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
19 | $79 | $277 |
| MRI of lower spine, without contrast A magnetic resonance imaging scan of the lower spinal canal that does not use contrast dye to create detailed images of the spine. |
19 | $158 | $602 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
18 | $416 | $1,339 |
| Electrocardiogram, 1 to 3 leads A test that records the electrical activity of the heart using one to three electrodes placed on the body. |
17 | $5 | $18 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
17 | $0 | $0 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
12 | $104 | $395 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.0% high complexity
22.9% medium
70.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,918
Total received (2018-2024)
Avg $1,131/year across 7 years
Top 5% in TX for anesthesiology
41
Companies
172
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,918 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,078
2023
$654
2022
$428
2021
$518
2020
$702
2019
$3,412
2018
$1,126
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Vertiflex, Inc.
$1,501
Nevro Corp.
$1,369
Abbott Laboratories
$1,103
PAINTEQ LLC
$788
Stryker Corporation
$659
Flowonix Medical Incorporated
$373
Medtronic, Inc.
$342
Medtronic USA, Inc.
$157
Boston Scientific Corporation
$157
BOSTON SCIENTIFIC CORPORATION
$125
Allergan Inc.
$121
Pacira Pharmaceuticals Incorporated
$95
Radius Health, Inc.
$75
Allergan, Inc.
$71
GRT US Holding, Inc.
$70
GlaxoSmithKline, LLC.
$66
SPR Therapeutics, Inc
$64
Flexion Therapeutics, Inc.
$52
Vertos Medical, Inc.
$51
Relievant Medsystems, Inc.
$51
Horizon Therapeutics plc
$50
Biohaven Pharmaceuticals, Inc.
$49
Nalu Medical, Inc.
$45
Saluda Medical Americas, Inc.
$43
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$41
Novartis Pharmaceuticals Corporation
$39
Fidia Pharma USA Inc.
$37
VERTEX PHARMACEUTICALS INCORPORATED
$33
ABIOMED
$30
Grifols USA, LLC
$28
Electronic Waveform Lab, Inc.
$28
BioDelivery Sciences International, Inc.
$27
Averitas Pharma Inc.
$26
Collegium Pharmaceutical, Inc.
$24
Teva Pharmaceuticals USA, Inc.
$22
Scilex Pharmaceuticals Inc.
$22
Lundbeck LLC
$20
Verity Pharmaceuticals Inc.
$17
TerSera Therapeutics LLC
$17
Amarin Pharma Inc.
$17
Baudax Bio Inc.
$14
Top 3 companies account for 50.2% of total payments
Associated products mentioned in payments ›
ACCURIAN · AIMOVIG · AJOVY · ANJESO · BELBUCA · BOTOX · BOTOX THERAPEUTIC · DUEXIS · EXPAREL · Evoke SCS · GENERAL - PAIN MANAGEMENT · GENERAL THERAPIES · Gamunex-C · HYALGAN · HYMOVIS · INTELLIS · INTELLIS ADAPTIVESTIM · IVS - VERTEBRAL AUGMENTATION PRODUCTS · Impella · Intracept · NORTHERA · NURTEC ODT · Nalu Neurostimulation System · Omnia · PAINTEQ · PENNSAID · PROCLAIM · Prialt · Proclaim Family of SCS IPGs · Prometra II · QUTENZA · Qutenza · RELISTOR · SHINGRIX · SPECTRA WAVEWRITER · SPRINT PNS System · SYNCHROMEDII · Senza · Senza Spinal Cord Stimulation System · Superion ISS · Superion Indirect Decompression System · Trelstar · Tymlos · V-LOC 180 · V-Loc · Vascepa · XTAMPZA · ZTLido · Zilretta · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for anesthesiology in TX.
Equivalent to $232 per 100 Medicare services performed
Geographic Context
Anesthesiologists within 10 mi
639
Per 100K population
13.4
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE CLEAR LAKE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ahmed is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), with low-engagement industry engagement in the top 5% of TX peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ahmed experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Ahmed performed 982 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ahmed receive payments from pharmaceutical companies?
Yes. Dr. Ahmed received a total of $7,918 from 41 companies across 172 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ahmed's costs compare to other anesthesiologists in Webster?
Dr. Ahmed's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ahmed) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Anesthesiologists in Webster
Browse anesthesiologists in Webster ranked by procedure volume and transparency data.
Highest volume
Top Anesthesiologists in TX
Anesthesiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Anesthesiologists in TX
Which TX anesthesiologists receive the most from drug and device companies.
By company
Vertiflex, Inc. Payments to Doctors
See all physicians who received payments from Vertiflex, Inc.
By company
Nevro Corp. Payments to Doctors
See all physicians who received payments from Nevro Corp.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology